Skip to main content
. 2024 Feb 6;26(3):262–273. doi: 10.1111/jch.14778

FIGURE 3.

FIGURE 3

(A) Achievement rate of the BP target (msSBP/msDBP < 140/90 mmHg) at 4 and 8 weeks of treatment ( p < .05 vs. TRE by Cochran‐Mantel‐ Haensqel test). (B) The mean msSBP from baseline to 4 and 8 weeks (* p < .0001 and p < .05 vs. TRE by independent t‐test). msDBP, mean sitting diastolic blood pressure; msSBP, mean sitting systolic blood pressure; RE, rosuvastatin/ezetimibe; T, telmisartan; TRE, telmisartan/rosuvastatin/ezetimibe.